In this episode of the Huberman Lab podcast, Dr. Thaïs Aliabadi and Andrew Huberman explore several key women's health conditions that affect millions. They discuss Polycystic Ovary Syndrome (PCOS), examining its symptoms, underlying causes, and treatment approaches, as well as endometriosis, detailing the challenges of diagnosis and current treatment options.
The conversation also covers breast cancer risk assessment and screening protocols, including the use of the Tyrer-Cuzick model for risk calculation. Aliabadi and Huberman address the broader issue of women's health conditions being overlooked in medicine, discussing how the healthcare system's constraints can impact proper diagnosis and treatment, while offering insights on how women can advocate for appropriate medical care.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
According to Thaïs Aliabadi, Polycystic Ovary Syndrome (PCOS) affects 15-20% of women of reproductive age, making it the most common hormonal disorder among women. Diagnosis requires two of three criteria: high androgens (causing acne, facial hair, or male-pattern hair loss), ovulation dysfunction (irregular periods), and polycystic ovaries visible on ultrasound.
Aliabadi explains that PCOS stems from multiple factors, including disrupted brain-ovary feedback, [restricted term] resistance, inflammation, and genetic factors. Despite its prevalence, over 90% of cases remain undiagnosed or improperly treated. Treatment typically involves managing [restricted term] resistance through lifestyle changes, medications like [restricted term], and supplements such as inositol. For women trying to conceive, fertility medications like [restricted term] or [restricted term] can help stimulate ovulation.
Dr. Aliabadi describes endometriosis as an autoimmune inflammatory condition where uterine-like tissue grows outside the uterus. Diagnosis typically takes 9-11 years and multiple doctor visits, with patients usually diagnosed around age 32. Common symptoms include painful periods, painful sex, chronic pelvic pain, bowel/bladder issues, and potential infertility.
Treatment options include hormonal suppression, pain management, and surgical excision. Aliabadi notes that there's a shortage of doctors trained in surgical removal of endometriosis, which is considered the gold standard for treatment.
Dr. Aliabadi emphasizes the importance of the Tyrer-Cuzick model for calculating breast cancer risk. This model considers factors like age, weight, breast density, and family history. Women with a lifetime risk of 20% or higher should begin annual screenings at age 30, rather than the standard age of 40.
For high-risk women (over 35% risk), Aliabadi outlines several management options, including regular imaging, medication like [restricted term], or preventive mastectomy.
Dr. Aliabadi and Andrew Huberman discuss the systematic dismissal of women's health issues in medicine. They note that doctors often overlook proper testing for conditions like PCOS and endometriosis, sometimes dismissing symptoms entirely. The current healthcare system's time constraints can lead to generic treatments without thorough investigation.
Aliabadi proposes separating obstetrics from gynecology to allow for better specialized care. Both experts emphasize the importance of women self-advocating and insisting on proper testing when experiencing unexplained symptoms.
1-Page Summary
Polycystic Ovary Syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, affecting 15-20% of women, with higher prevalence in certain regions. Thaïs Aliabadi and other experts delve into the various aspects of this condition, including symptoms, causes, and treatments.
The diagnosis of PCOS requires two of the following three criteria: high androgens, ovulation dysfunction, and polycystic ovaries on ultrasound. High androgens are indicated by acne, facial hair, or male-pattern hair thinning, while ovulation dysfunction is characterized by irregular periods. On ultrasound, a polycystic appearance is often a "string of pearls" with 20 or more follicles.
Aliabadi highlights disrupted brain-ovary feedback, [restricted term] resistance, inflammation, and genetic/epigenetic factors as underlying causes. [restricted term] resistance, in particular, drives many symptoms of PCOS, including difficulty losing weight and mood disorders.
Despite its prevalence, over 90% of women with PCOS remain undiagnosed or improperly treated. Misconceptions and lack of awareness contribute to the misdiagnosis and mistreatment of this condition.
Treatment begins with managing [restricted term] resistance through lifestyle changes and can include medication such as [restricted term]. Supplements like inositol and a balanced diet are also crucial. Hormonal treatments such as birth control can help manage symptoms like acne and facial hair.
Aliabadi stresses the importance of addressing PCOS holistically, considering not just symptoms but also underlying causes. Lifestyle plays a crucial role in managing PCOS, with emphasis on exercise, diet, stress reduction, and adequate sleep.
For women trying to conceive, fertility medications such as [restricted term] or [restricted term] can stimulate ovulation. Aliabadi suggests that women with symptoms of high [restricted term] likely are not ovulating, which underscores the need for fertility assessment and treatment tailored to the individual's hormonal profile.
Addressing the underlying condition is key to managing PCOS effectively. Treatments for PCOS are multi-faceted and should be individualized to target both the metabolic and hormonal imbalances associated with the disorder.
Moreover, for long-term managemen ...
Pcos: Symptoms, Diagnosis, Underlying Causes, and Treatments
Dr. Thaïs Aliabadi delves into the multifaceted aspects of endometriosis, underscoring the commonality of the condition, its misdiagnosis, and the various treatment methods. Endometriosis is characterized as an often overlooked autoimmune inflammatory condition where uterine-like tissue grows outside of the uterus, leading to pain and infertility.
Thaïs Aliabadi reveals that endometriosis affects a significant portion of women, many of whom remain undiagnosed. On average, it takes nine to eleven years for doctors in the United States to diagnose the condition with patients seeing an average of five to ten doctors, and some have seen up to fifty. The age of diagnosis is typically around 32 after a long journey of chronic pelvic pain or infertility issues.
Aliabadi details the symptoms of endometriosis, including painful periods, painful sex with deep penetration, GI pain, bloating, chronic pelvic pain, leg pain, and potential infertility. As the disease progresses, patients may also experience worsening premenstrual and postmenstrual pain that can disrupt daily activities. Painful periods that increasingly impact life suggest endometriosis until proven otherwise.
Endometriosis leads to internal bleeding outside the uterus and it can cause scarring in the pelvis, affect the quality of a woman's eggs, and create a hostile environment for sperm, eggs, and embryos, which increases the risk of infertility, ectopic pregnancy, and miscarriage. Adenomyosis, a sister condition to endometriosis, is also common among these patients and contributes to heavy periods and painful sex. Patients with endometriosis may have autoimmune conditions, making it advisable to ask for a full autoimmune panel.
Endometriosis: Symptoms, Diagnosis, and Treatments
As discussed by Thaïs Aliabadi, understanding one's risk for breast cancer involves more nuanced guidelines and methods for early screening and prevention.
Thaïs Aliabadi sheds light on the Tyrer-Cuzick model, also known as the breast cancer risk calculator, which assesses a woman's lifetime risk of developing breast cancer.
The model factors in a range of personal details, including age, height, weight, breast density, family history, and genetic predispositions. Breast density information, crucial for the risk assessment, can be sourced from mammograms or MRIs.
Aliabadi underscores the inadequacy of current screening guidelines, revealing that her own lifetime breast cancer risk was calculated at 37% using the Tyrer-Cuzick model. Women with a lifetime risk of 20% or higher should start annual screenings for breast cancer at the age of 30—ten years earlier than the often-advised age of 40.
Drawing from her experience, Aliabadi explains the crucial nature of early diagnosis and treatment, particularly for those with significant family histories of cancer. The podcast stresses the importance of considering family history as part of breast cancer risk assessment, as any histor ...
Breast Cancer Risk Assessment and Screening
Women face significant challenges in the medical field, with critical health issues like polycystic ovary syndrome (PCOS) and endometriosis often encountering dismissal and delayed diagnoses by doctors. Personal advocacies and changes in medical practices are needed to address this pervasive issue.
Dr. Thaïs Aliabadi and Andrew Huberman address the problem of underdiagnosis or dismissal of conditions like endometriosis and PCOS, suggesting a profound gap in the medical system's handling of these women's health issues. For instance, doctors often misunderstand PCOS as merely a presence of cysts, despite it being an ultrasound finding, and endometriosis patients face devastating side effects because physicians do not take the time to listen. Aliabadi recounts that patients with severe period pain or suspected endometriosis are sometimes told they are too young to have fertility issues. Additionally, Aliabadi points out that PCOS-looking ovaries might be dismissed by doctors without properly examining or understanding the condition, even offering mistaken reassurances regarding fertility.
Dr. Aliabadi highlights that non-typical PCOS presentations, including patients who are thin or without overt symptoms, contribute to the condition's misdiagnosis, further complicated by varied phenotypes of PCOS. Further, pelvic MRI and ultrasounds are mentioned as crucial but often overlooked tests, and Aliabadi contends that a normal result does not mean a person does not have endometriosis.
Doctors with constrained schedules may default to providing generic treatments, such as birth control, without conducting a thorough investigation. Dr. Aliabadi criticizes the healthcare system for only allowing 10 minutes with a doctor, which can result in insufficient diagnosis and treatment. The structure, including handling of insurance, could pressure physicians into a "conveyor belt" type of practice, limiting the time they can devote to complex health issues such as endometriosis.
Dr. Aliabadi proposes separating obstetrics from gynecology, enabling gynecologists to be better trained in recognizing conditions like PCOS and endometriosis. She envisions that specializ ...
Women's Health Underdiagnosis and Dismissal by Medicine
Download the Shortform Chrome extension for your browser
